This document discusses ocular melanoma research being conducted at Erasmus Medical Center. It provides the following key points: - Approximately 140 patients per year are diagnosed with ocular melanoma between ages 50-70. Treatment involves removing the eye or radiation, but 50% still develop metastases with a poor prognosis. Research aims to find prognostic markers. - Samples including blood, tumor tissue, and healthy tissue are collected from patients. Various tests are conducted including arrays, next-generation sequencing, fluorescence in situ hybridization, and quantitative PCR. - Clinical data and samples from over 900 individuals and 10,000 samples are stored. A research support tool and governance model tracks samples and associated data across analysis and storage. T